049IC - Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment

Sunday, April 30, 2023

7:30 AM – 9:30 AM CST

Location: S102C

Instructional Course Director(s)

Benjamin Lee, MD

Professor & Chair, The George W. Drach, MD Endowed Chair, Department of Urology
University of Arizona College of Medicine

Instructional Course Faculty(s)

AS

A. Oliver Sartor, MD

Tulane Medical School
Chandru Sundaram, MD, FACS, FRCS

Welch Professor of Urology, Vice Chair and Program Director
Indiana University School of Medicine

Course Description: Treatment of renal cell carcinoma (RCC) has changed with expanding indications for robotic partial nephrectomy and inclusion of new U.S. Food and Drug Administration-approved treatments for advanced RCC. This course will focus on didactic case discussions using video tape analysis of surgical treatment, setup and successful completion of robotic partial nephrectomy, complication management and how to optimize outcomes. Urologists are now faced with treatment of advanced RCC with a host of options, from tyrosine kinase inhibitors to mTOR inhibitors. There will be discussion focused on how to monitor and algorithms for when to switch treatment.

Learning Objectives:

Engage and improve knowledge base on new U.S. Food and Drug Administration approved immunotherapy and checkpoint inhibitors for treatment and counseling of advanced RCC.
Apply knowledge base from complex didactic case discussion for management of patients in their own clinic.
Identify indications, risks and benefit of neoadjuvant tyrosine kinase Inhibitors for downsizing renal cell carcinoma.